Thrombotic microangiopathy in a patient with Sezary syndrome treated with interferon-alpha.
Politou
Marianna
M
First Department of Internal Medicine, University of Athens Medical School, Greece. mpolitou@hotmail.com
Tsaftarides
Panagiotis
P
Vassiliades
John
J
Siakantaris
Marina P
MP
Michail
Spyros
S
Nakopoulou
Lydia
L
Pangalis
Gerassimos A
GA
Vaiopoulos
George
G
D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D007668:Kidney / Q000098:blood supply; D007674:Kidney Diseases / Q000139:chemically induced*; D008297:Male; D008833:Microcirculation / Q000473:pathology; D008875:Middle Aged; D012751:Sezary Syndrome / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy*; D013927:Thrombosis / Q000139:chemically induced*
D000970:Antineoplastic Agents; D016898:Interferon-alpha